Form 4 for SDGR Schrodinger, Inc.
Accepted 2023-08-10 00:00:00 ET · period of report 2023-08-09 · accession 0001490978-23-000099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-10 | 2023-08-09 | SDGR | Dugan Margaret | Chief Medical Off | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 |
| D | 2023-08-10 | 2023-08-09 | SDGR | Dugan Margaret | Chief Medical Off | A - Grant | $0.00 | +90.0K | 90.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-09 | A | A | 15,000 | $0.00 | 15,000 | D | — | — | (F1) Grant of restricted stock units ("RSUs") under the Issuer's 2021 Inducement Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on August 9, 2023 and will vest in equal installments on each of October 15, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continued service with the company. (F2) Includes 15,000 unvested RSUs. |
| 2 | Derivative | Stock Option (right to buy) | 2023-08-09 | A | A | 90,000 | $0.00 | 90,000 | D | $39.89 · — to 2033-08-09 | 90,000 Common Stock | (F3) The option was granted on August 9, 2023 under the Issuer's 2021 Inducement Equity Incentive Plan. The shares underlying the option are scheduled to vest with respect to 25% of the shares on July 31, 2024 and the remainder are scheduled to vest in equal monthly installments through July 31, 2027. |